Zeitplan konkretisiert: Haleon-IPO: GlaxoSmithKline plant Börsengang der Konsumentensparte Mitte Juli - Pfizer will aus Haleon aussteigen | Nachricht | finanzen.net
London's largest listing for a decade sees Haleon demerged from GSK | Business News | Sky News
Haleon debuts with lacklustre valuation - Business & Industry | News | Analysis | Magazines- Asian Trader
Haleon plc: Bullish On The Market's Newest Consumer Healthcare Blue Chip (NYSE:HLN) | Seeking Alpha